Market Place
Sourcing Support
UK probes GLP-1 drugs` potential suicide risks
27 Jul 2023 //
FIERCE PHARMA
Sanofi Aventis Adlyxin (Lixisenatide) Receives Approval in the U.S.
10 Jun 2022 //
FDA
SMC recommends Suliqua for restricted use in combination with metformin
16 Apr 2020 //
PHARMIWEB
Sanofi talks up personalized diabetes care in patient-centric awareness push
10 Jun 2019 //
FIERCE PHARMA
US FDA approves expanded use of Soliqua 100/33
28 Feb 2019 //
PHARMABIZ
Tetraphase antibiotic may reach up to $700 million in annual sales: CEO
09 Feb 2017 //
REUTERS
EU approval for Sanofi’s diabetes combo
18 Jan 2017 //
PHARMATIMES
EU approval of Suliqua(TM) triggers USD 10 million milestone payment to Zealand
17 Jan 2017 //
GLOBENEWSWIRE
Sanofi beats Novo to launch with diabetes combo Soliqua
06 Jan 2017 //
FIERCE PHARMA
Platypus venom could give rise to a new class of diabetes treatments
30 Nov 2016 //
FIERCE BIOTECH
Novo, Sanofi go head to head as FDA clears new diabetes drugs
24 Nov 2016 //
JAPAN TODAY
FDA Approves Sanofi`s Combination Diabetes Drug
22 Nov 2016 //
DDDMAG
USFDA Approves Soliqua 100/33 for the Treatment of Adults with Type 2 Diabetes
22 Nov 2016 //
GLOBENEWSWIRE
Sanofi`s Soliqua Receives Approval In US
21 Nov 2016 //
FDA
Nine Therapies Put Forward for EU Approval
15 Nov 2016 //
PHARMATIMES
CHMP issues positive opinion recommending Suliqua for approval in the EU
11 Nov 2016 //
GLOBENEWSWIRE
Sanofi loses lead on diabetes combo IGlarLixi after FDA delay
22 Aug 2016 //
PMLIVE
Sanofi provides update on NDA for daily FDC of insulin glargine & lixisenatide
22 Aug 2016 //
PHARMABIZ
Sanofi Receives FDA Approval of Adlyxin™ for Treatment of Type 2 Diabetes
27 Jul 2016 //
PR NEWSWIRE
IDegLira receives unanimous 16-0 vote in favor of approval from FDA Advisory Committee
25 May 2016 //
GLOBAL NEWS WIRE
New T2D Drugs Face Skeptical FDA Advisors
24 May 2016 //
MEDPAGE TODAY
FDA Accepts Sanofi NDA for Combination of Insulin Glargine and Lixisenatide
23 Feb 2016 //
PR NEWSWIRE
Sanofi Announces Soliqua 100/33 Now Available in the U.S.
10 Jan 2016 //
DDDMAG
Sanofi Seeks FDA Approval for Diabetes Drug Combination
28 Dec 2015 //
NASDAQ
Sanofi uses priority review voucher for diabetes combo
26 Dec 2015 //
PM LIVE
Sanofi takes an FDA shortcut with its diabetes combo, racing with Novo
24 Dec 2015 //
FIERCE BIOTECH
Sanofi submits new diabetes drug application to U.S. regulator
22 Dec 2015 //
REUTERS
Lyxumia`s may help Sanofi`s case for approval,but won`t score against SGLT2s
03 Dec 2015 //
FIERCE PHARMA
Sanofi`s back-to-growth strategy fails to impress analysts
10 Nov 2015 //
FIERCE PHARMA
Sanofi Files U.S. Drug Application for Lixisenatide
28 Sep 2015 //
NASDAQ
Zealand Pharma gains 20% after PhIII success clears path to diabetes payday
17 Sep 2015 //
FIERCE BIOTECH
Victoza tops Sanofi`s Lyxumia in trial, adding to Novo`s GLP-1 arsenal
16 Sep 2015 //
FIERCE PHARMA
No change in CV risk for ACS patients on Sanofi`s Lyxumia
31 Aug 2015 //
FIERCE PHARMA
Sanofi`s Lixilan Hits Phase III Goal
29 Jul 2015 //
BIOSPACE
Sanofi`s combination diabetes drug hits goal in late-stage trial
28 Jul 2015 //
REUTERS
Sanofi will resubmit Lyxumia for FDA approval in Q3
10 Jun 2015 //
PM LIVE
FDA staff question utility, trials of Novo Nordisk diabetes drug
21 May 2015 //
REUTERS
Sanofi`s Diabetes Franchise One Step Closer To U.S. Lyxumia Launch
20 Mar 2015 //
FIERCE PHARMA
